Table 1. Clinicopathological characteristics in patients with benign and malignant renal disease before nephrectomy.
| Benign disease (n=12) | Renal cancer (n=64) | P-value | |
|---|---|---|---|
| Age group (⩽60/>60 years) | 9/3 | 35/29 | 0.194 |
| Sex (male/female) | 4/8 | 42/22 | 0.037 |
| T stage (1/2/3/4) | 27/4/21/12 | ||
| Tumour volume (cm3) | 112 (1–4864) | ||
| Fuhrman grade (1/2/3/4) | 8/16/21/13 | ||
| Operation (curative/cytoreductive) | 54/10 | ||
| ECOG-PS (0/1) | 12/0 | 53/11 | 0.123 |
| Haemoglobin (⩾12/<12 g dl−1) | 9/3 | 50/14 | 0.813 |
| White cell count | |||
| (<8.5/8.5–11.0/>11.0 109 l−1) | 7/5/0 | 48/13/3 | 0.486 |
| Lymphocyte percentage | |||
| (20–40/12.0–19.9/0–11.9%) | 10/2/0 | 43/15/6 | 0.199 |
| Albumin (⩾35/<35 g l−1) | 11/0 | 59/3 | 0.459 |
| C-reactive protein (⩽10/>10 mg l−1) | 8/4 | 34/30 | 0.390 |
| Interleukin-6 (pg ml−1) | <2 (<2–19) | 4 (<2–142) | 0.007 |
| Interleukin-6 (⩽4/>4 pg ml−1) | 10/1 | 33/31 | 0.015 |
| Interleukin-10 (pg ml−1) | <4 (<4–7) | 6 (<4–66) | 0.012 |
| Interleukin-10 (⩽10/>10 pg ml−1) | 12/0 | 45/19 | 0.030 |
ECOG, Eastern Cooperative Oncology Group.
Median (range).